Hereby, Bruton's tyrosine kinase (Btk) has been shown to be essential for several constitutively active pathways implicated in CLL cell survival, including the Akt, ERK and NF-κB pathway [8–11]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.